The pluripotency of ES cells, combined with their ease of genetic manipulation and selection, has revolutionized gene functional studies in vivo via the generation of transgenic, chimeric and knockout mice. New technologies are evolving that will make the ability to perform appropriate manipulations of ES cells even more important for the next generation of mouse mutants (Draper and Nagy, 2007). These include, for example, the combination of inducible recombinases (Cre and Flp) for regulated temporal and spatial ablation of genes, RNAi, and development of new techniques that accelerate generation of completely ES cell derived FO mice (i.e. tetraploid aggregation and laser-assisted injection). The main service of Core 4 is to provide to NINDS-funded Qualifying Investigators a high level of expertise in mouse ES cell targeting in order to permit the efficient generation of animal models for neurobiological research. In addition to ES cell electroporation and characterization, the staff of the Core 4 will work with the NINDS-funded investigators to establish and characterize ES cell lines from a number of genetic backgrounds (particularly C57BI/6) that allow mice to be generated on a pure genetic background. Finally, Core 4 will maintain a bank of genetically marked ES cell lines. The ES cells and mice generated from these lines will be used for in vivo lineage tracing and in vitro differentiation into neuronal and glial cell lines.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Center Core Grants (P30)
Project #
5P30NS045892-09
Application #
8374466
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Project Start
Project End
Budget Start
2011-12-01
Budget End
2012-11-30
Support Year
9
Fiscal Year
2012
Total Cost
$118,511
Indirect Cost
$38,436
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Crowther, Andrew J; Lim, Szu-Aun; Asrican, Brent et al. (2018) An Adeno-Associated Virus-Based Toolkit for Preferential Targeting and Manipulating Quiescent Neural Stem Cells in the Adult Hippocampus. Stem Cell Reports 10:1146-1159
Allard, Denise E; Wang, Yan; Li, Jian Joel et al. (2018) Schwann cell-derived periostin promotes autoimmune peripheral polyneuropathy via macrophage recruitment. J Clin Invest 128:4727-4741
Yeh, Chia-Yu; Asrican, Brent; Moss, Jonathan et al. (2018) Mossy Cells Control Adult Neural Stem Cell Quiescence and Maintenance through a Dynamic Balance between Direct and Indirect Pathways. Neuron 99:493-510.e4
Thaxton, Courtney; Kloth, Alexander D; Clark, Ellen P et al. (2018) Common Pathophysiology in Multiple Mouse Models of Pitt-Hopkins Syndrome. J Neurosci 38:918-936
Song, Liujiang; Llanga, Telmo; Conatser, Laura M et al. (2018) Serotype survey of AAV gene delivery via subconjunctival injection in mice. Gene Ther 25:402-414
Zhang, Jing; Wu, Tao; Simon, Jeremy et al. (2018) VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma. Science 361:290-295
Boyer, Nicholas P; Monkiewicz, Caroline; Menon, Shalini et al. (2018) Mammalian TRIM67 Functions in Brain Development and Behavior. eNeuro 5:
Sidorov, Michael S; Judson, Matthew C; Kim, Hyojin et al. (2018) Enhanced Operant Extinction and Prefrontal Excitability in a Mouse Model of Angelman Syndrome. J Neurosci 38:2671-2682
McCoy, Eric S; Taylor-Blake, Bonnie; Aita, Megumi et al. (2017) Enhanced Nociception in Angelman Syndrome Model Mice. J Neurosci 37:10230-10239
Hutton, Scott R; Otis, James M; Kim, Erin M et al. (2017) ERK/MAPK Signaling Is Required for Pathway-Specific Striatal Motor Functions. J Neurosci 37:8102-8115

Showing the most recent 10 out of 158 publications